EMERGENT BIOSOLUTIONS INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2023-12-11: Form 10-Q; Exhibit 10.2; Description Form of Letter Agreement, dated July 26, 2023.
- 2023-12-11: Form 10-Q; Exhibit 10.1; Description Emergent BioSolutions Inc. Inducement Plan.
- 2023-10-02: Form 8-K; Exhibit 10.1; Description Emergent BioSolutions Inc. Inducement Plan.
- 2023-08-09: Form 10-Q; Exhibit 10.10; Description Consulting Agreement, dated as of July 7, 2023 and effective as of Jul 7, 2023, by and between Emergent BioSolutions Inc. and Haywood Miller..
| Filed | Form | Exhibit | Description |
|---|
| 2023-12-11 | 10-Q | 10.2 | Form of Letter Agreement, dated July 26, 2023 |
|---|
| 2023-12-11 | 10-Q | 10.1 | Emergent BioSolutions Inc. Inducement Plan |
|---|
| 2023-10-02 | 8-K | 10.1 | Emergent BioSolutions Inc. Inducement Plan |
|---|
| 2023-08-09 | 10-Q | 10.10 | Consulting Agreement, dated as of July 7, 2023 and effective as of Jul 7, 2023, by and between Emergent BioSolutions Inc. and Haywood Miller. |
|---|
| 2023-08-09 | 10-Q | 10.7 | Modification No. 10, effective May 26, 2023, to the ACAM2000 Contract. |
|---|
| 2023-08-09 | 10-Q | 10.6 | Modification No. 9, effective May 24, 2023, to the ACAM2000 Contract. |
|---|
| 2023-08-09 | 10-Q | 10.5 | Modification No. 14, effective March 30, 2023, to the BARDA AV7909 Contract. |
|---|
| 2023-08-09 | 10-Q | 10.4 | Modification No. 13, effective March 30, 2023, to the BARDA AV7909 Contract. |
|---|
| 2023-05-18 | 8-K | 10.2 | Equity Distribution Agreement, dated May 17, 2023, between Emergent BioSolutions Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC. |
|---|
| 2023-05-18 | 8-K | 10.1 | Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement, dated May 15, 2023, among Emergent BioSolutions Inc., the guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent. |
|---|
| 2023-05-10 | 10-Q | 10 | Form of 2023-2025 Performance Based Stock Unit Award Agreement. |
|---|
| 2023-03-23 | 8-K | 10 | Form of 2023-2025 Performance Based Stock Unit Award Agreement |
|---|
| 2023-03-01 | 10-K | 10.204 | Purchase and Sale Agreement dated February 15, 2023 by and between Emergent BioSolutions Inc., through its wholly owned subsidiaries Emergent International Inc. and Emergent Travel Health Inc. and Bavarian Nordic. |
|---|
| 2023-03-01 | 10-K | 10.10 | Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan Approved by the Compensation Committee of the Board of Directors of Emergent BioSolutions Inc. on January 4, 2023. |
|---|
| 2023-03-01 | 10-K | 10.4 | Consent, Limited Waiver, and Third Amendment to the Amended and Restated Credit Agreement, dated February 14, 2023. |
|---|